Want to see PRPH full AI Analyst Report?
Earnings Data
Report Date
Aug 06, 2026TBA (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
―Last Year’s EPS
-0.11Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call highlighted several promising developments, such as the Crown Medical collections, potential partnerships for the esophageal cancer test, and a turnaround in the Nebula Genomics business. However, these positives were counterbalanced by significant challenges, including financial constraints, a declining stock price, and the need for a reverse stock split to maintain Nasdaq compliance. The company is actively pursuing strategic initiatives to address these issues and improve shareholder value.Company Guidance
Crown Medical Collections Initiative
Crown Medical has been appointed special counsel to collect $150 million in uncollected COVID testing claims. They expect to collect at least $50 million net, which could significantly improve the company's financial situation.
B Smart Esophageal Cancer Test
The esophageal cancer test is considered one of the best diagnostic tests for one of the deadliest cancers. Now that it's been published in a major journal, it has attracted interest from various companies looking to partner or acquire.
Nebula Genomics Business Turnaround
The Nebula Genomics business has been restructured to become primarily direct-to-consumer, with a subscription model that is profitable on a pro forma basis.
Potential Strategic Initiatives
The company is exploring multiple strategic initiatives, including potential M&A deals and partnerships, which could significantly enhance shareholder value. They are also considering a crypto treasury strategy once cash flow improves.
PRPH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
PRPH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 07, 2026 | $0.14 | $0.12 | -14.29% |
Apr 15, 2026 | $0.14 | $0.15 | +7.14% |
Nov 19, 2025 | $2.58 | $2.33 | -9.53% |
Aug 13, 2025 | $3.54 | $3.27 | -7.51% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Prophase Labs (PRPH) report earnings?
Prophase Labs (PRPH) is schdueled to report earning on Aug 06, 2026, TBA (Confirmed).
What is Prophase Labs (PRPH) earnings time?
Prophase Labs (PRPH) earnings time is at Aug 06, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PRPH EPS forecast?
Currently, no data Available